Amarantus' Presentations - AAIC Meeting, July 12-1
Post# of 30028
Posted On: 07/05/2014 10:51:05 AM
Amarantus' Presentations - AAIC Meeting, July 12-17, 2014 in Copenhagen, Denmark
Employing Lymphocyte Proliferation as a means to Asses Cell Cycle Dys-regulation in Cognitively Impaired Subjects: Clinical Performance of the LymPro Assay
P2-389
11:45am - 2:15pm
Mon, Jul 14
Employing Lymphocyte Proliferation as a means to Asses Cell Cycle Dys-regulation in Cognitively Impaired Subjects: Analytical Performance of the LymPro Assay
P3-117
11:45am - 2:15pm
Tue, Jul 15
Retrospective Analysis of Clinical Prognosis of Subjects from a 2005 study using the LymPro assay
P3-118
11:45am - 2:15pm
Tue, Jul 15
Great time to announce a "big pharma" marketing partnership for LymPro. Roche in the E.U. and Quest Diagnostics in the U.S. would make great partners.
Stay tuned for news.
Note: Jason Napadano tweeted that his next article on Amarantus would be after the AAIC meeting.
Twitter: @AmarantusBio .... 9,955 followers.
p.s. Expecting the share price to move substantially higher from here through the up-listing in 4Q2014. Major milestones ahead.
Employing Lymphocyte Proliferation as a means to Asses Cell Cycle Dys-regulation in Cognitively Impaired Subjects: Clinical Performance of the LymPro Assay
P2-389
11:45am - 2:15pm
Mon, Jul 14
Employing Lymphocyte Proliferation as a means to Asses Cell Cycle Dys-regulation in Cognitively Impaired Subjects: Analytical Performance of the LymPro Assay
P3-117
11:45am - 2:15pm
Tue, Jul 15
Retrospective Analysis of Clinical Prognosis of Subjects from a 2005 study using the LymPro assay
P3-118
11:45am - 2:15pm
Tue, Jul 15
Great time to announce a "big pharma" marketing partnership for LymPro. Roche in the E.U. and Quest Diagnostics in the U.S. would make great partners.
Stay tuned for news.
Note: Jason Napadano tweeted that his next article on Amarantus would be after the AAIC meeting.
Twitter: @AmarantusBio .... 9,955 followers.
p.s. Expecting the share price to move substantially higher from here through the up-listing in 4Q2014. Major milestones ahead.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼